Literature DB >> 28486463

First eczema biologic debuts but price could restrict use.

Elie Dolgin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28486463     DOI: 10.1038/nbt0517-391

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  IL-17-targeting biologics aim to become standard of care in psoriasis.

Authors:  Mark Ratner
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

2.  Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis.

Authors:  Thomas Ruzicka; Jon M Hanifin; Masutaka Furue; Grazyna Pulka; Izabela Mlynarczyk; Andreas Wollenberg; Ryszard Galus; Takafumi Etoh; Ryosuke Mihara; Hiroki Yoshida; Jonathan Stewart; Kenji Kabashima
Journal:  N Engl J Med       Date:  2017-03-02       Impact factor: 91.245

3.  Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Authors:  Eric L Simpson; Thomas Bieber; Emma Guttman-Yassky; Lisa A Beck; Andrew Blauvelt; Michael J Cork; Jonathan I Silverberg; Mette Deleuran; Yoko Kataoka; Jean-Philippe Lacour; Külli Kingo; Margitta Worm; Yves Poulin; Andreas Wollenberg; Yuhwen Soo; Neil M H Graham; Gianluca Pirozzi; Bolanle Akinlade; Heribert Staudinger; Vera Mastey; Laurent Eckert; Abhijit Gadkari; Neil Stahl; George D Yancopoulos; Marius Ardeleanu
Journal:  N Engl J Med       Date:  2016-09-30       Impact factor: 91.245

  3 in total
  2 in total

1.  Drugmakers cling to dual IL-13/IL-4 blockbuster hopes.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908

2.  First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis.

Authors:  Ian A Myles; Noah J Earland; Erik D Anderson; Ian N Moore; Mark D Kieh; Kelli W Williams; Arhum Saleem; Natalia M Fontecilla; Pamela A Welch; Dirk A Darnell; Lisa A Barnhart; Ashleigh A Sun; Gulbu Uzel; Sandip K Datta
Journal:  JCI Insight       Date:  2018-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.